Results 191 to 200 of about 5,953 (226)

HBV, HCV, and HDV Triple-Infection-A Therapeutic Challenge. [PDF]

Diseases
Balta AAS, Ignat MD, Barbu RE, Baroiu L, Moroianu LA, Lutenco V, Bulza V, Patriciu M, Dumitru C, Debita M.   +9 more
europepmc   +1 more source

ĐÁNH GIÁ CẢI THIỆN TÌNH TRẠNG XƠ HÓA GAN KHI ĐIỀU TRỊ PHÁC ĐỒ SOFOSBUVIR/VELPATASVIR/RIBAVIRIN TRÊN BỆNH NHÂN VIÊM GAN C MẠN TÍNH CÓ XƠ GAN

Van-Trang Dinh, Thị Liên Hà Nguyễn
openalex   +2 more sources

Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C. [PDF]

Gastro Hep Adv
Ying X, Zhao A, Ng N, Rosenblatt R, Lucero C, Jesudian AB.   +5 more
europepmc   +1 more source

Direct-Acting Antiviral Treatment Failure and Retreatment Strategies Following Hepatitis C-Positive Solid Organ Transplantation in Hepatitis C-Negative Recipients: A Multicenter Case Series. [PDF]

Transpl Infect Dis
Carver AB, Özoral C, Lange M, Mattise A, Whelchel K, Perri R.   +5 more
europepmc   +1 more source

Sustained Virological Response After Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Individuals With and Without Decompensated Liver Cirrhosis: A One-Year Follow-Up Study. [PDF]

Cureus
Shailja, Radera S, Rungta S, Jeet A, Jain A.   +4 more
europepmc   +1 more source

Clinical outcomes and patient-reported measures in HCV care: Insight from a longitudinal prospective study in a large Italian region. [PDF]

PLoS One
Moretti G, Tramonti Fantozzi MP, Corazza I, De Vita E, Vainieri M, Tavoschi L, OPT-HepaC project team.   +6 more
europepmc   +1 more source

Direct-Acting Antivirals Quickly Eradicate Hepatitis C Virus From the Liver in People With Human Immunodeficiency Virus but Do Not Fully Reverse Immune Activation. [PDF]

J Infect Dis
Sachithanandham J, Leep-Lazar J, Quinn J, Bowden K, Balasubramaniam P, Ward K, Ribeiro RM, Sulkowski MS, Balagopal A.   +8 more
europepmc   +1 more source

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure [PDF]

core   +2 more sources

Trends in Utilization and Costs Following a Hepatitis C Elimination Initiative. [PDF]

JAMA Netw Open
Tabah A, Basu A, Cox-North P, Zerzan-Thul J, Evaskus L, Sullivan D, Colson J, Huriaux E, Stockton J, Heidari O, Wiggins L, Chang S, Kohler P.   +12 more
europepmc   +1 more source

Understanding the cascade of care and predictors of treatment success among patients with hepatitis C - A prospective study at a tertiary care center in India. [PDF]

IJID Reg
Rai SK, Oberoi S, Singh A, Singh H.
europepmc   +1 more source